Has Andrew Osborn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,196 in general payments to Andrew Osborn, MD across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Osborn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Osborn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Osborn, MD

Ophthalmology · Springfield, MONPI 1811493729

Payments from drug & device makers

$4,196in general payments, 2019–2025

Across 101 payments — averaging $41.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$2K
Glaukos Corporation$527
Sight Sciences, Inc.$395
AbbVie$341
Johnson & Johnson Surgical Vision, Inc.$335
Rxsight Inc$227
plus $825 from 11 others

What the payments were for

Food & beverage$4,09698%
Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	33	$1,547
Glaukos Corporation	12	$527
Sight Sciences, Inc.	6	$395
AbbVie(2 entities)	10	$341
Johnson & Johnson Surgical Vision, Inc.	9	$335
Rxsight Inc	3	$227
Nova Eye, Inc.	3	$163
Bausch & Lomb Americas Inc.	6	$120
Ocular Therapeutix, Inc.	3	$119
Amgen(2 entities)	5	$95
Carl Zeiss Meditec USA, Inc.	1	$93
Tarsus Pharmaceuticals, Inc.	2	$61
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$49
Sun Pharmaceutical Industries Inc.	2	$44
Alimera Sciences, Inc.	2	$38
Leadiant Biosciences, Inc.	1	$26
Aerie Pharmaceuticals, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,196 in reported general payments places this provider in the 65th percentile of 286 ophthalmology providers in Missouri.

See all ophthalmology providers in Missouri →

Medicare billing

Part B allowed, 2024

$284,440

Medicare patients

484

Services billed

2,159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	359	$8,186
Ketorolac Tromethamine	216	$4,314
Ofloxacin	262	$2,877
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	25	$2,037
Latanoprost	246	$1,980
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	61	$1,101
ErythromycinErythromycin Base	87	$901
MoxifloxacinMoxifloxacin Hcl	12	$585
Timolol Maleate	123	$481
Brimonidine Tartrate	67	$423
Dorzolamide Hcl	17	$403
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	28	$333

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Springfield

Shachar TauberSpringfield$265K
Wendell ScottSpringfield$142K
Thomas PraterSpringfield$30K
Nancy HolekampChesterfield$2.7M
Steven SilversteinKansas City$1.6M
Joseph TauberKansas City$1.3M
Steven CouchSaint Louis$1.2M
Andrew MoyesKansas City$1.1M
Ranjan MalhotraSaint Louis$964K
Navin TekwaniSaint Louis$957K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →